| Literature DB >> 26725042 |
Isaac Mugwano1, Mark Kaddumukasa2, Levi Mugenyi3,4, James Kayima5, Edward Ddumba6, Martha Sajatovic7, Cathy Sila8, Michael DeGeorgia9, Elly Katabira10.
Abstract
BACKGROUND: Raised blood pressure (BP) remains an important risk factor for cardiovascular diseases such as stroke. Adherence to therapeutic recommendations especially antihypertensive drugs is important in BP control. The aim of the study was to assess the stroke risk factors and levels of adherence among hypertensive patients with stroke in Kampala Uganda.Entities:
Mesh:
Substances:
Year: 2016 PMID: 26725042 PMCID: PMC4698320 DOI: 10.1186/s13104-015-1830-4
Source DB: PubMed Journal: BMC Res Notes ISSN: 1756-0500
Demographic characteristics of study participants (n= 112)
| Demographic characteristics | |
|---|---|
| Age in years, median (IQR) | 63.5 (52.5–75.0) |
| Age categories | |
| ≤40 years | 7 (6.3) |
| 41–50 years | 14 (12.5) |
| 51–60 years | 26 (23.2) |
| 61–70 years | 26 (23.2) |
| 71–80 years | 24 (21.4) |
| >80 years | 15 (13.4) |
| Gender, n (%) | |
| Male | 46 (41.1) |
| Marital status, n (%) | |
| Single | 9 (8.0) |
| Married | 81 (72.3) |
| Cohabiting | 0 (0.0) |
| Divorced | 7 (6.3) |
| Widowed | 15 (13.4) |
| Address, n (%) | |
| Rural | 49 (43.7) |
| Urban | 63 (56.3) |
| Occupation, n (%) | |
| Peasant farmer | 51 (45.5) |
| Gainful employment | 48 (42.9) |
| Retired or unemployed | 13 (11.6) |
| Education level, n (%) | |
| None | 32 (28.6) |
| 1–7 years in school | 52 (46.4) |
| 8–13 years in school | 6 (5.4) |
| >13 years in school | 22 (19.6) |
Distribution of study participants by blood pressure variables (n = 112)
| Blood pressure variable | n (%) |
|---|---|
| Duration since diagnosed with blood pressure (years), Median (IQR) | 4.5 (2–10) |
| Routine care, n (%) | |
| Yes | 45 (40.2) |
| Frequency of review, n (%) | |
| Not reviewed | 64 (57.1) |
| Monthly | 32 (28.6) |
| Every 2 months | 6 (5.4) |
| Every 3 months | 10 (8.9) |
| Current treatment for hypertension, n (%) | |
| Yes | 53 (47.3) |
| Drugs participant uses for blood pressure, n (%) | |
| Calcium channel blockers | 43 (39.1) |
| Diuretics | 14 (12.7) |
| Β-blockers | 15 (13.6) |
| ACEIs/ARBs | 37 (33.6) |
| Alpha–adrenergic agonist (methyldopa) | 1 (1) |
| Drug therapy, n (%) | |
| Mono-therapy | 16 (28.1) |
| Duo-therapy | 33 (57.9) |
| Multi-therapy | 8 (14.0) |
| Lipid lowering therapy, n (%) | |
| Yes | 3 (2.6) |
| Herbal medication, n (%) | |
| Yes | 37 (33.0) |
| Family history of hypertension, n (%) | |
| Yes | 59 (52.7) |
| Challenges experienced on drugs, n (%) | |
| Cost | 47 (42.3) |
| Access | 9 (8.1) |
| Side effects | 4 (3.6) |
| Pill load | 3 (2.7) |
| None | 45 (40.5) |
| Previous diagnosis of diabetes mellitus, n (%) | |
| Yes | 24 (21.4) |
| Currently on medication for diabetes, n (%) | |
| Yes | 21 (87.5) |
| Level of control for sugar, n (%) | |
| Good | 20 (95.2) |
| Poor | 1 (4.8) |
History of clinical characteristics and life style among study participants (N = 112)
| History of heart disease, n (%) | Yes | 8 (7.1) |
| Previous diagnosis of HIV, n (%) | Yes | 4 (3.6) |
| Previous history of stroke, n (%) | Yes | 14 (12.5) |
| Family history of stroke, n (%) | Yes | 9 (8.0) |
| Warfarin therapy, n (%) | Yes | 3 (2.7) |
| Current history of smoking, n (%) | Yes | 2 (1.8) |
| Current history of alcohol consumption, n (%) | Yes | 19 (17.0) |
| Previous history of smoking, n (%) | Yes | 3 (2.7) |
| Pack years, median (IQR) | 10 (9–10) | |
| Regular exercise, n (%) | Yes | 36 (32.1) |
Distribution of study participants by their cholesterol levels (N = 112)
| Total cholesterol, n (%) | |
| <200 (normal) | 54 (60.0) |
| 200–239 (border line high) | 20 (22.2) |
| ≥240 (high) | 16 (17.8) |
| HDL cholesterol, n (%) | |
| >40 (desirable) | 61 (67.8) |
| ≤40 (lower than desired) | 29 (32.2) |
| LDL cholesterol, n (%) | |
| <100 (optimal) | 28 (31.1) |
| 100–129 (near optimal) | 24 (26.7) |
| 130–159 (border line high) | 23 (25.6) |
| 160–189 (high) | 9 (10.0) |
| ≥190 (very high) | 6 (6.7) |
| Fasting triglycerides, n (%) | |
| <150 (normal) | 44 (80.0) |
| 150–199 (border line high) | 5 (9.1) |
| 200–499 (high) | 5 (9.1) |
| >500 (very high) | 1 (1.8) |
Fig. 1Shows the anti-hypertensive medication adherence according to the Morisky drug score
Fig. 2Shows the reasons for low drug adherence among the study participants